Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Tamas Treuer"'
Autor:
Blanca Hernández-Cruz, Uta Kiltz, Jérôme Avouac, Tamas Treuer, Ewa Haladyj, Jens Gerwien, Chandreyee Dutta Gupta, Fabrizio Conti
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 6, Pp 1417-1457 (2023)
Abstract Introduction Baricitinib, an orally available small-molecule inhibitor of Janus kinase (JAK)1 and JAK2, is indicated to treat active moderate-to-severe rheumatoid arthritis (RA). Objective This systematic review described the real-world clin
Externí odkaz:
https://doaj.org/article/9dea967ec8f74009a3c381369d954236
Autor:
Sabina Ciciriello, Geoffrey Littlejohn, Tamas Treuer, Kathryn A. Gibson, Ewa Haladyj, Peter Youssef, Paul Bird, Catherine O'Sullivan, Tegan Smith, Claire T. Deakin, OPAL Rheumatology
Publikováno v:
ACR Open Rheumatology, Vol 5, Iss 7, Pp 345-353 (2023)
Objective To analyze comparative treatment persistence for first‐line baricitinib (BARI) versus first‐line tumor necrosis factor inhibitor (TNFi) in patients with rheumatoid arthritis (RA) and for first‐line BARI initiated as monotherapy versus
Externí odkaz:
https://doaj.org/article/4d2c347dcd0d4556b637deb60b95cc9a
Autor:
Adam Reich, Catherine Reed, Christopher Schuster, Camille Robert, Tamas Treuer, Ennio Lubrano
Publikováno v:
Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)
Objectives To describe the results of a structured literature review of real-world outcomes with ixekizumab in patients with psoriasis (PsO) and/or psoriatic arthritis (PsA). Methods Literature databases, conference proceedings and additional sources
Externí odkaz:
https://doaj.org/article/3ceea8fb79db4779ac1ee1052d5b3662
Autor:
Koichi Hirata, Kaname Ueda, Wenyu Ye, Yongin Kim, Mika Komori, James Jackson, Sarah Cotton, Narayan Rajan, Tamas Treuer
Publikováno v:
BMC Neurology, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Real-world data on sufficient/insufficient response, and predictors of insufficient response, to acute treatments for migraine are limited in Japan. This study aimed to identify factors associated with insufficient response to acu
Externí odkaz:
https://doaj.org/article/d21a178688634026b194250f283b3e13
Autor:
Takao Takeshima, Qi Wan, Yanlei Zhang, Mika Komori, Serina Stretton, Narayan Rajan, Tamas Treuer, Kaname Ueda
Publikováno v:
The Journal of Headache and Pain, Vol 20, Iss 1, Pp 1-15 (2019)
Abstract Background The objective of this review was to determine the unmet needs for migraine in East Asian adults and children. Methods We searched MEDLINE and EMBASE (January 1, 1988 to January 14, 2019). Studies reporting the prevalence, humanist
Externí odkaz:
https://doaj.org/article/004b71dbe7ac4802a3f902552a9dc55e
Autor:
Kaname Ueda, Wenyu Ye, Louise Lombard, Atsushi Kuga, Yongin Kim, Sarah Cotton, James Jackson, Tamas Treuer
Publikováno v:
The Journal of Headache and Pain, Vol 20, Iss 1, Pp 1-11 (2019)
Abstract Background In Japan, detailed information on the characteristics, disease burden, and treatment patterns of people living with migraine is limited. The aim of this study was to compare clinical characteristics, disease burden, and treatment
Externí odkaz:
https://doaj.org/article/9caf85c686f34a719e9b74e8fc8cef88
Autor:
Qiang Shi, Ko-Jen Li, Tamas Treuer, Bruce C M Wang, Carol L Gaich, Chien-Hsun Lee, Wen-Shuo Wu, Wesley Furnback, Chao-Hsiun Tang
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0193489 (2018)
BACKGROUND:Previous studies in Taiwan utilizing the Taiwan's National Health Insurance Database (NHIRD) have estimated the direct healthcare costs of RA patients, but they have not focused on patients on bDMARDs, or considered patients' response to t
Externí odkaz:
https://doaj.org/article/8b49987eae7b4882b7b53097f1a9ee48
Autor:
Murat Altin, Ahmed A El-Shafei, Maria Yu, Durisala Desaiah, Tamas Treuer, Nikolay Zavadenko, Hong Yun Gao
Publikováno v:
Drugs in Context, Pp 1-12 (2013)
Objective: Functional outcomes were measured over a 12-month period in children and adolescents with attention deficit hyperactivity disorder (ADHD) after they received monotherapy. Design: Prospective, observational, noninterventional study. Sett
Externí odkaz:
https://doaj.org/article/d92ae375b38d4b4098e28dd27f40b985
Autor:
Chao-Hsiun, Tang, Yao-Hsien, Huang, Po-Ya, Chuang, Bruce C M, Wang, Ching-Yun, Wei, Khai Jing, Ng, Tamas, Treuer, Chia-Yu, Chu
Publikováno v:
Dermatology and Therapy. 12:2547-2562
The objective of this study was to conduct a retrospective analysis to understand the patient profile, treatment patterns, healthcare resource utilization, and cost of atopic dermatitis (AD) of patients eligible for targeted therapy in Taiwan.A retro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8627b329f96658f0ca9f1e4f3d4fc150
https://doi.org/10.1007/s13555-022-00816-9
https://doi.org/10.1007/s13555-022-00816-9
Autor:
Jacques Morel, Lorenzo Dagna, Beatriz Joven Ibañez, Thorsten Holzkaemper, Celine El Baou, Leonore Unger, Angelo Semeraro, Nicola Gullick, Tamas Treuer
Publikováno v:
Rheumatology. 62
Background/Aims Ixekizumab (ixe), a highly selective interleukin (IL)-17A monoclonal antibody, has been approved for treatment of psoriatic arthritis (PsA). However, there is limited real-world evidence (RWE) available for ixe. PRO-SPIRIT is the firs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cab04e4130b1adfc972fbc3f9de895b6
https://doi.org/10.1093/rheumatology/kead104.225
https://doi.org/10.1093/rheumatology/kead104.225